Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
162.74
-1.27 (-0.78%)
Oct 6, 2026, 12:07 PM EDT - Market open
Glaukos Market Cap
Glaukos has a market cap or net worth of $9.59 billion as of October 6, 2026. Its market cap has increased by 91.39% in one year.
Market Cap
9.59B
Enterprise Value
9.42B
1-Year Change
91.39%
Ranking
Category
Stock Price
$162.74
ChartMarket Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $9.59B, an increase of 859.80%. That is a compound annual growth rate of 22.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 9.59B | 47.94% |
| Dec 31, 2025 | 6.49B | -21.56% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | - |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
| Jun 25, 2015 | 999.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| STERIS | 20.62B |
| Zimmer Biomet Holdings | 17.27B |
| Penumbra | 12.52B |
| 10x Genomics | 11.17B |
| Smith & Nephew | 11.17B |
| Globus Medical | 10.25B |
| Bio-Rad Laboratories | 10.08B |
| Bio-Rad Laboratories | 9.94B |